We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70
Avg Time Held
12 quarters
Top 10 Avg Time Held
12 quarters
Top 20 Avg Time Held
10.4 quarters

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CRH icon
326
CRH
CRH
$53.3B
$4.29M 0.04%
+57,279
New +$4.57M
2024 Q2
0 quarters
IFF icon
327
International Flavors & Fragrances
IFF
$22.5B
$4.28M 0.04%
44,941
+9,891
+28% +$907K
2020 Q2
16 quarters
LII icon
328
Lennox International
LII
$12.1B
$4.27M 0.04%
7,986
+2,674
+50% +$1.32M
2020 Q2
16 quarters
HWM icon
329
Howmet Aerospace
HWM
$86.5B
$4.25M 0.04%
54,774
+2,588
+5% +$196K
2020 Q2
16 quarters
EL icon
330
Estee Lauder
EL
$36.1B
$4.25M 0.04%
39,960
+911
+2% +$120K
2020 Q2
16 quarters
VLTO icon
331
Veralto
VLTO
$24.1B
$4.12M 0.04%
43,122
+11,726
+37% +$1.12M
2023 Q4
2 quarters
PTC icon
332
PTC
PTC
$21.1B
$4.09M 0.04%
22,492
+1,069
+5% +$191K
2020 Q2
16 quarters
NDAQ icon
333
Nasdaq
NDAQ
$52.3B
$4.06M 0.04%
67,449
-353
-0.5% -$21.4K
2020 Q2
16 quarters
MANH icon
334
Manhattan Associates
MANH
$13B
$4.04M 0.04%
16,360
-1,077
-6% -$244K
2020 Q2
16 quarters
CSGP icon
335
CoStar Group
CSGP
$12.2B
$4.03M 0.04%
54,313
-15,858
-23% -$1.34M
2020 Q2
16 quarters
HSY icon
336
Hershey
HSY
$32.8B
$4.01M 0.04%
21,840
-8,607
-28% -$1.67M
2020 Q2
16 quarters
HAL icon
337
Halliburton
HAL
$27.3B
$4.01M 0.04%
118,667
-19,545
-14% -$721K
2020 Q2
16 quarters
PPG icon
338
PPG Industries
PPG
$23.2B
$4M 0.04%
31,793
-5,751
-15% -$762K
2020 Q2
16 quarters
XEL icon
339
Xcel Energy
XEL
$46.6B
$3.99M 0.04%
74,681
-95
-0.1% -$5.17K
2020 Q2
16 quarters
EIX icon
340
Edison International
EIX
$21.3B
$3.97M 0.04%
55,352
-2,405
-4% -$174K
2020 Q2
16 quarters
ZBH icon
341
Zimmer Biomet
ZBH
$17.6B
$3.96M 0.04%
36,459
-864
-2% -$102K
2020 Q2
16 quarters
DG icon
342
Dollar General
DG
$27.6B
$3.95M 0.04%
29,895
-20,325
-40% -$2.84M
2020 Q2
16 quarters
ON icon
343
ON Semiconductor
ON
$29.9B
$3.91M 0.04%
57,098
-426
-0.7% -$29.9K
2021 Q2
12 quarters
CLX icon
344
Clorox
CLX
$10.2B
$3.88M 0.04%
28,451
+181
+0.6% +$25.1K
2020 Q2
16 quarters
ES icon
345
Eversource Energy
ES
$24.8B
$3.85M 0.04%
67,935
-7,657
-10% -$454K
2020 Q2
16 quarters
CHTR icon
346
Charter Communications
CHTR
$12.2B
$3.85M 0.04%
12,862
-9,686
-43% -$2.64M
2020 Q2
16 quarters
WAB icon
347
Wabtec
WAB
$48.4B
$3.81M 0.04%
24,112
-515
-2% -$82.3K
2020 Q2
16 quarters
BURL icon
348
Burlington
BURL
$16.5B
$3.79M 0.04%
15,803
-832
-5% -$171K
2020 Q2
16 quarters
WTW icon
349
Willis Towers Watson
WTW
$27.6B
$3.78M 0.04%
14,433
-1,617
-10% -$417K
2020 Q2
16 quarters
FITB icon
350
Fifth Third Bancorp
FITB
$45.5B
$3.78M 0.04%
103,661
+4,104
+4% +$150K
2020 Q2
16 quarters

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.